Depomed Finds New Promotion Partner For ProQuin XR
This article was originally published in The Pink Sheet Daily
Executive Summary
Company enters profit-splitting agreement with Watson less than a month after taking ciprofloxacin product back from Esprit.
You may also be interested in...
Depomed Takes ProQuin XR Rights Back From Esprit
Firm will leverage its Glumetza commercial structure to sell and distribute the proprietary ciprofloxacin formulation in the U.S.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
Alzheimer’s, BRAIN Initiative Highlighted In $30 Billion NIH Budget Proposal
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.